Patents by Inventor Yongxing Zhang

Yongxing Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11431392
    Abstract: The present disclosure relates to methods for feeding back channel state information, user equipment, and base stations. One example method includes receiving a reference signal sent by a base station, selecting a precoding matrix W from a codebook according to the reference signal, where a column vector of the precoding matrix W is expressed as ?[v ej?v]T, v=[1 ej?], and sending a precoding matrix indicator (PMI) to the base station, where the PMI corresponds to the selected precoding matrix W.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: August 30, 2022
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Jianguo Wang, Yongxing Zhou, Leiming Zhang
  • Patent number: 11407734
    Abstract: Provided is a preparation method for a tyrosine kinase inhibitor and an intermediate thereof. Specifically, a preparation method for a cyanoquinoline compound is provided. The method has a high yield, good product purity, and mild reaction conditions.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: August 9, 2022
    Assignee: Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Guobing Feng, Yongxing Cao, Peng Zhang, Zhenjun Qiu, Long Zhang
  • Patent number: 11405858
    Abstract: A wireless access method and apparatus, the method including sending N first signal sets on N first resources, where N is an integer greater than 1, receiving Z response signals from a terminal for the N first signal sets, where each response signal of the response signals comprises indication information of a resource on which the respective first signal set of the N first signal sets is located, Z is an integer greater than or equal to 1, and Z is less than or equal to N, and sending M second signal sets on M second resources according to the Z response signals, where M is an integer greater than or equal to 1, and each second signal set of the M second signal sets corresponds to at least one of the N first signal sets.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: August 2, 2022
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Kunpeng Liu, Yongxing Zhou, Leiming Zhang
  • Publication number: 20220233827
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: April 12, 2022
    Publication date: July 28, 2022
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Patent number: 11317967
    Abstract: Magnetic guided ablation catheters and methods of manufacture are disclosed. In an exemplary embodiment, a catheter includes a unitary flexible tubing having a proximal end and a distal end. A plurality of magnets are positioned along an axis of the unitary flexible tubing, the plurality of magnets provided within the unitary flexible tubing. During operation, the plurality of magnets are responsive to an external magnetic field to selectively position and guide the catheter within a body of a patient.
    Type: Grant
    Filed: November 16, 2018
    Date of Patent: May 3, 2022
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Kirk Kochin Wu, Yongxing Zhang
  • Publication number: 20200398032
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: September 2, 2020
    Publication date: December 24, 2020
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Publication number: 20200360671
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: August 6, 2020
    Publication date: November 19, 2020
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Patent number: 10758713
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: September 1, 2020
    Assignee: Neurotronic, Inc.
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Publication number: 20200206456
    Abstract: A lumen extension member is provided for a catheter having a catheter body and an elongate electrode coupled to the catheter body. The elongate electrode defines an electrode lumen extending therethrough. The lumen extension member is positioned within the electrode lumen and is coupled to the catheter body. The lumen extension member includes a tubular member including a sidewall and at least one opening that extends through the sidewall.
    Type: Application
    Filed: January 14, 2020
    Publication date: July 2, 2020
    Inventors: Alan de la Rama, Cary Hata, William Du, Yongxing Zhang
  • Patent number: 10576244
    Abstract: A lumen extension member is provided for a catheter having a catheter body and an elongate electrode coupled to the catheter body. The elongate electrode defines an electrode lumen extending therethrough. The lumen extension member is positioned within the electrode lumen and is coupled to the catheter body. The lumen extension member includes a tubular member including a sidewall and at least one opening that extends through the sidewall.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: March 3, 2020
    Assignee: ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
    Inventors: Alan de la Rama, Cary Hata, William Du, Yongxing Zhang
  • Publication number: 20200016379
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: September 6, 2019
    Publication date: January 16, 2020
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Publication number: 20200009355
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: September 6, 2019
    Publication date: January 9, 2020
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Publication number: 20190274687
    Abstract: Embodiments of the present invention provide a magnetic anastomosis device (MAD), a delivery catheter for the MAD, and a method for treating at least one of diabetes, obesity, digestive disease, and non-alcoholic fatty liver disease. In embodiments of the present invention, a pair of the MADs are delivered in body lumen by endoscopic and/or laparoscopic techniques. An anastomosis between two adjacent body lumens is formed by compression of the pair of MADs followed by necrosis and regeneration of the lumen tissue. The bodily fluids are then redirected through the formed anastomosis to relieve disease symptoms.
    Type: Application
    Filed: September 20, 2017
    Publication date: September 12, 2019
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang, Craig C. Belton, Shannon R. Stroud, Richard Cornelius, Scott Naisbitt
  • Publication number: 20190175266
    Abstract: Magnetic guided ablation catheters and methods of manufacture are disclosed. In an exemplary embodiment, a catheter includes a unitary flexible tubing having a proximal end and a distal end. A plurality of magnets are positioned along an axis of the unitary flexible tubing, the plurality of magnets provided within the unitary flexible tubing. During operation, the plurality of magnets are responsive to an external magnetic field to selectively position and guide the catheter within a body of a patient.
    Type: Application
    Filed: November 16, 2018
    Publication date: June 13, 2019
    Inventors: Kirk Kochin Wu, Yongxing Zhang
  • Patent number: 10286191
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue, In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: May 14, 2019
    Assignee: Neurotronic, Inc.
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Publication number: 20190038881
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: October 10, 2018
    Publication date: February 7, 2019
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Patent number: 10130421
    Abstract: Magnetic guided ablation catheters and methods of manufacture are disclosed. In an exemplary embodiment, a catheter includes a unitary flexible tubing having a proximal end and a distal end. A plurality of magnets are positioned along an axis of the unitary flexible tubing, the plurality of magnets provided within the unitary flexible tubing. During operation, the plurality of magnets are responsive to an external magnetic field to selectively position and guide the catheter within a body of a patient.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: November 20, 2018
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Kirk Kochin Wu, Yongxing Zhang
  • Patent number: 10039598
    Abstract: A catheter includes a flexible tubing having a proximal end and a distal end. The catheter also includes an electrode assembly attached to the distal end of the flexible tubing and having a first magnet therein. The electrode assembly further includes an electrically conductive tip electrode and an electrically nonconductive coupler which is connected between the tip electrode and the distal end of the flexible tubing. The coupler and the tip electrode are coupled by an interlocking connection. The catheter also includes a second magnet spaced from the electrode assembly along a longitudinal axis of the tubing. The first magnet and the second magnet are responsive to an external magnetic field to selectively position and guide the electrode assembly within a body of a patient.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: August 7, 2018
    Assignee: ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
    Inventors: Alan de la Rama, Kirk Kochin Wu, Yongxing Zhang
  • Publication number: 20180015264
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue, In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Application
    Filed: October 30, 2015
    Publication date: January 18, 2018
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Patent number: D963566
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: September 13, 2022
    Assignee: 3A TECHNOLOGY CO., LIMITED
    Inventors: Shisheng Huang, Yongxing Wang, Baiguang Zhang